Precision Biologics
  • Home
  • Company
    • About Us
    • Contact Us
    • Board
    • Leadership
  • Clinical
    • Pipeline
    • Companion Diagnostics
    • Therapeutics
    • Clinical Trials
  • Science
    • Publications
      • Recent
      • Historical
    • Abstracts
    • Posters
    • Presentations
  • News and Events
Search
  • Home
  • Company
    • About Us
    • Contact Us
    • Board
    • Leadership
  • Clinical
    • Pipeline
    • Companion Diagnostics
    • Therapeutics
    • Clinical Trials
  • Science
    • Publications
      • Recent
      • Historical
    • Abstracts
    • Posters
    • Presentations
  • News and Events
  • Home
  • News and Events
  • News

News

18MarMarch 18, 2016

NCI Investigators Collaborate with Moonshoot 2020

Strattmont Group2016-03-18T21:36:12-04:00

https://twitter.com/nciresearchctr/status/694520668679962624

Facebook Twitter LinkedIn
Read more...
21JanJanuary 21, 2016

Precision Biologics Reaches First Clinical Trial Milestone: Immunotherapy Trial Demonstrates Encouraging Survival Rates in Patients with Metastatic Colorectal Cancer‎ Who Failed all Standard Therapy

Strattmont Group2019-12-17T20:21:45-05:00

Over 30% of patients who failed all standard chemo and antibody therapy remain alive after...

Facebook Twitter LinkedIn
Read more...
21DecDecember 21, 2015

Precision Biologics, Announces Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI)

Strattmont Group2019-12-17T20:12:08-05:00

December 21, 2015 08:00 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)-- Today Precision Biologics Inc,...

Facebook Twitter LinkedIn
Read more...
20AugAugust 20, 2015

Beth Israel Deaconess Medical Center (BIDMC) Joins Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial

Strattmont Group2015-08-20T03:17:57-04:00

Precision Biologics is pleased to announce the addition of Beth Israel Deaconess (BIDMC)as a collaborator...

Facebook Twitter LinkedIn
Read more...
18JunJune 18, 2015

Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts General Hospital (MGH) Join Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial

Strattmont Group2015-06-18T14:55:55-04:00

Precision Biologics is pleased to announce the addition of Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts...

Facebook Twitter LinkedIn
Read more...
02JunJune 2, 2015

Dr. Philip Arlen to Speak at 16th Annual Drug Discovery Summit

Strattmont Group2019-12-06T07:20:22-05:00

Dr. Philip Arlen will be speaking at this years Drug Discovery Summit June 8-9th in...

Facebook Twitter LinkedIn
Read more...
20MayMay 20, 2015

Precision Biologics Completes Patient Accrual to its Ensituximab Phase 2 Colorectal Cancer Study

Strattmont Group2015-05-20T21:57:23-04:00

FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...

Facebook Twitter LinkedIn
Read more...
18MayMay 18, 2015

Yale Cancer Center and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Joins Precision Biologics as Collaborators

Strattmont Group2015-05-18T13:50:43-04:00

Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...

Facebook Twitter LinkedIn
Read more...
12MayMay 12, 2015

Notice of Annual Meeting of Stockholders To Be Held on June 12, 2015

Strattmont Group2015-05-12T02:18:37-04:00

PRECISION BIOLOGICS, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 12, 2015 at 6:00...

Facebook Twitter LinkedIn
Read more...
03FebFebruary 3, 2015

PRNewswire: EMD Millipore Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services

Strattmont Group2015-02-03T03:38:30-05:00

DARMSTADT, Germany, Feb. 2, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business...

Facebook Twitter LinkedIn
Read more...
  Prev1…67

Featured News

Precision Biologics to present data on new antibody-drug conjugate PB-223 ADC at AACR, Chicago, IL, April 25 – 30, 2025
April 25, 2025
Dr. Philip M Arlen to present at Festival of Biologics USA, San Diego, CA, April 23 – 24, 2025
April 18, 2025
Precision Biologics highlighted in GEN article, April 2025 issue
April 18, 2025
Want To Find Out More?

CONTACT INFO

301-500-8646

4922 Fairmont Avenue, Suite 320
Bethesda, MD 20814

COMPANY

Board
About Us
Contact Us
News and Events

CLINICAL

Pipeline
Diagnostics
Therapeutics
Clinical Trials

SCIENCE

Recent Publications
Publications – Historical
Abstracts
Posters
Presentations

© Copyright 2019-2025. Precision Biologics. All Rights Reserved.
Website Development By Strattmont Group